Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Type 2 diabetes (T2D) is reduced in postmenopausal women randomized to estrogen-based hormone therapy (HT) compared with placebo. Insulin sensitivity is a key determinant of T2D risk and overall cardiometabolic health, and studies indicate that estradiol (E2) directly impacts insulin action. OBJECTIVE: We hypothesized that the timing of E2 administration after menopause is an important determinant of its effect on insulin action. DESIGN: We performed a randomized, crossover, placebo-controlled study. PARTICIPANTS: Study participants were early postmenopausal (EPM; ≤ 6 years of final menses; n = 22) and late postmenopausal (LPM; ≥ 10 years since last menses; n = 24) women naive to HT. INTERVENTION: Study interventions included short-term (1 week) transdermal E2 and placebo. MAIN OUTCOMES AND MEASURES: The study's main outcome was insulin-mediated glucose disposal (glucose disposal rate [GDR]) via hyperinsulinemic-euglycemic clamp. RESULTS: Compared to EPM women, LPM women were older (mean ± SD; 63 ± 3 vs 56 ± 4 years, P < .05) and more years past menopause (12 ± 2 vs 3 ± 2 years, P < .05). Body mass index (24 ± 3 vs 25 ± 7 kg/m(2)) and fat mass (25 ± 7 vs 23 ± 6 kg) did not differ between groups, but fat-free mass (FFM) was lower in LPM women compared to EPM women (40 ± 4 vs 43 ± 5 kg, P < .05). Baseline GDR did not differ between groups (11.7 ± 2.8 vs 11.5 ± 2.9 mg/kg FFM/min). In support of our hypothesis, 1 week of E2 decreased GDR in LPM women compared to an increase in EPM women (+0.44 ± 1.7 vs - 0.76 ± 2.1 mg/kg FFM/min, P < .05). CONCLUSIONS: There was not an apparent decline in GDR with age or time since menopause per se. However, E2 action on GDR was dependent on time since menopause, such that there was an apparent benefit early (≤ 6 years) compared to harm later (≥ 10 years) in menopause. E2-mediated effects on insulin action may be one mechanism by which HT reduces the incidence of T2D in early postmenopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many studies have shown that E2 beneficially influences metabolism through mechanisms involving reduced food intake and increased energy expenditure (75, 129–131).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [131]
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
A survey for assessing physical activity among older adults
DIPIETRO, L., CASPERSEN, C. J., OSTFELD, A. M., & NADEL, E. R. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199305000-00016 · Cited by 708
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Santen, R. J., Allred, D. C., Ardoin, S. P., Archer, D. F., Boyd, N., Braunstein, G. D., Burger, H. G., Colditz, G. A., Davis, S. R., Gambacciani, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2509 · Cited by 680
Salpeter, S. R., Walsh, J. M. E., Ormiston, T. M., Greyber, E., Buckley, N. S., & Salpeter, E. E. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00545.x · Cited by 640
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00005 · Cited by 633
for the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599
Grodstein, F., Manson, J. E., & Stampfer, M. J. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.35 · Cited by 479
Estrogen and Mechanisms of Vascular Protection
Xing, D., Nozell, S., Chen, Y.-F., Hage, F., & Oparil, S. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.182279 · Cited by 379
Harman, S. M., Black, D. M., Naftolin, F., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hopkins, P. N., Lobo, R. A., Manson, J. E., Merriam, G. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0353 · Cited by 344
Insulin resistance in aging is related to abdominal obesity
Kohrt, W. M., Kirwan, J. P., Staten, M. A., Bourey, R. E., King, D. S., & Holloszy, J. O. (1993) · Diabetes · doi:10.2337/diab.42.2.273 · Cited by 303
Contributions of total and regional fat mass to risk for cardiovascular disease in older women
Van Pelt, R. E., Evans, E. M., Schechtman, K. B., Ehsani, A. A., & Kohrt, W. M. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00467.2001 · Cited by 262
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s21 · Cited by 226
Bonds, D. E., Lasser, N., Qi, L., Brzyski, R., Caan, B., Heiss, G., Limacher, M. C., Liu, J. H., Mason, E., Oberman, A., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0096-0 · Cited by 213
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s21 · Cited by 208
Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women
Salpeter, S. R., Cheng, J., Thabane, L., Buckley, N. S., & Salpeter, E. E. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.021 · Cited by 201
Natali, A., Toschi, E., Baldeweg, S., Ciociaro, D., Favilla, S., Saccà, L., & Ferrannini, E. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1076 · Cited by 199
Clarkson, T. B. (2007) · Menopause · doi:10.1097/gme.0b013e31803c764d · Cited by 188
Influence of menopause on diabetes and diabetes risk
Szmuilowicz, E. D., Stuenkel, C. A., & Seely, E. W. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.166 · Cited by 162
Wilkerson, H. L. C., Cohen, A. S., & Kenadjian, B. G. (1955) · Journal of Chronic Diseases · doi:10.1016/0021-9681(55)90188-0 · Cited by 156
Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future
Clarkson, T. B., Meléndez, G. C., & Appt, S. E. (2013) · Menopause · doi:10.1097/gme.0b013e3182843aad · Cited by 156
Participation of ERα and ERβ in glucose homeostasis in skeletal muscle and white adipose tissue
Barros, R. P. A., Gabbi, C., Morani, A., Warner, M., & Gustafsson, J.-Å. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00189.2009 · Cited by 155
Hodis, H. N., Mack, W. J., Shoupe, D., Azen, S. P., Stanczyk, F. Z., Hwang-Levine, J., Budoff, M. J., & Henderson, V. W. (2015) · Menopause · doi:10.1097/gme.0000000000000343 · Cited by 152
Manson, J. E., Rimm, E. B., Colditz, G. A., Willett, W. C., Nathan, D. M., Arky, R. A., Rosner, B., Hennekens, C. H., Speizer, F. E., & Stampfer, M. J. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90011-e · Cited by 135
Lower-Body Adiposity and Metabolic Protection in Postmenopausal Women
Van Pelt, R. E., Jankowski, C. M., Gozansky, W. S., Schwartz, R. S., & Kohrt, W. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1764 · Cited by 130
Rogers, N. H., Witczak, C. A., Hirshman, M. F., Goodyear, L. J., & Greenberg, A. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.154 · Cited by 123
Tissue-Specific Effects of Loss of Estrogen during Menopause and Aging
Wend, K., Wend, P., & Krum, S. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00019 · Cited by 118
O'Sullivan, A. J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1783 · Cited by 116
Hodis, H. N., & Mack, W. J. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.06.011 · Cited by 79
Pedersen, S. B., Børglum, J. D., Møller‐Pedersen, T., & Richelsen, B. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90120-u · Cited by 74
Kien, C. L., & Ugrasbul, F. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.876 · Cited by 66
Intravenous estrogens increase insulin clearance and action in postmenopausal women
Van Pelt, R. E., Gozansky, W. S., Schwartz, R. S., & Kohrt, W. M. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00490.2002 · Cited by 64
Stumvoll, M., Jacob, S., Wahl, H. G., Hauer, B., Löblein, K., Grauer, P., Becker, R., Nielsen, M., Renn, W., & Häring, H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6898 · Cited by 63
Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study
Pentti, K., Tuppurainen, M. T., Honkanen, R., Sandini, L., Kröger, H., Alhava, E., & Saarikoski, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0151 · Cited by 60
MURAKI, K., OKUYA, S., & TANIZAWA, Y. (2006) · Endocrine Journal · doi:10.1507/endocrj.k06-005 · Cited by 57
Gabal, L. L., Goodman-Gruen, D., & Barrett-Connor, E. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.3.443 · Cited by 56
Stümvoll, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3740 · Cited by 43
Acute Modulation of Adipose Tissue Lipolysis by Intravenous Estrogens
Van Pelt, R. E., Gozansky, W. S., Hickner, R. C., Schwartz, R. S., & Kohrt, W. M. (2006) · Obesity · doi:10.1038/oby.2006.253 · Cited by 39
Effect of treatment with different doses of 17–β–estradiol on the insulin receptor
González, C., Alonso, A., Grueso, N. A., Esteban, M., Fernández, S., & Patterson, A. M. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01489-3 · Cited by 26
Insulin Secretion and Clearance after Subacute Estradiol Administration in Postmenopausal Women
Pelt, R. E. V., Schwartz, R. S., & Kohrt, W. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1657 · Cited by 16
Cited by
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Hormone-replacement therapy: current thinking
Lobo, R. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.164 · Cited by 484
Mauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
“Pereira (117) RCT 22 566 4 1 wk t-E2 50 mg Euglycemic, hyperinsulinemic clamp GDR ↑”
BackgroundHodis, H. N., & Mack, W. J. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000591 · Cited by 187
Sex Differences in Adipose Tissue Function
Gavin, K. M., & Bessesen, D. H. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.02.008 · Cited by 185
Metadata
- Authors
- Pereira, R. I., Casey, B. A., Swibas, T. A., Erickson, C. B., Wolfe, P., & Van Pelt, R. E.
- Affiliations
- Division of Geriatric Medicine; Department of Medicine (R.I.P., B.A.C.), Division of Endocrinology, Metabolism and Diabetes
- Department of Medicine (T.A.S., C.B.E., R.E.V.P.), Aurora, Colorado 80045
- Colorado School of Public Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-12-01
- Volume
- 100
- Issue
- 12
- Pages
- 4456-4462
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4667161
- OpenAlex
- W1680854225
- Cited by
- 59
- References
- 42
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 3 · 2019: 7 · 2018: 4 · 2017: 16 · 2016: 5
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Health and Care Research
- National Institutes of Health (UL1TR000154, UL1TR001082)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088105, T32DK007446, P30DK048520)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD073063)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- estradiol, hormone therapy, menopause, insulin sensitivity, glucose disposal rate, type 2 diabetes risk, postmenopausal women, timing of hormone therapy, transdermal estradiol, fat-free mass, hyperinsulinemic-euglycemic clamp, cardiometabolic health, age at menopause, body composition, skeletal muscle
- MeSH terms
- Age Factors, Aged, Body Composition, Diabetes Mellitus, Type 2, Estradiol, Female, Glucose, Glucose Tolerance Test, Humans, Insulin Resistance, Middle Aged, Motor Activity, Glucose Clamp Technique, Estrogen Replacement Therapy, Body Mass Index, Treatment Outcome, Postmenopause, Cross-Over Studies, Risk Reduction Behavior, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.